1. Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs
   Gene M Dubowchik et al, 1999, Pharmacology & Therapeutics CrossRef
2. Targeted anticancer prodrug therapy using dextran mediated enzyme–antibody conjugate and β-cyclodextrin-curcumin inclusion complex
   Sahar Roozbehi et al, 2020, International Journal of Biological Macromolecules CrossRef
3. Bystander killing of tumour cells by antibody-targeted enzymatic activation of a glucuronide prodrug
   T L Cheng et al, 1999, British Journal of Cancer CrossRef
4. Antibody-directed enzyme prodrug therapy (ADEPT): a review
   I Niculescu-Duvaz et al, 1997, Advanced Drug Delivery Reviews CrossRef
5. Glucarpidase (carboxypeptidase G2): Biotechnological production, clinical application as a methotrexate antidote, and placement in targeted cancer therapy
   Fatemeh Moradbeygi et al, 2023, Biomedicine & Pharmacotherapy CrossRef
6. Expression of chimeric monomer and dimer proteins on the plasma membrane of mammalian cells
   Wan-Chih Chou et al, 1999, Biotechnology and Bioengineering CrossRef
7. Sustained Tumor Regression of Human Colorectal Cancer Xenografts Using a Multifunctional Mannosylated Fusion Protein in Antibody-Directed Enzyme Prodrug Therapy
   Surinder K. Sharma et al, 2005, Clinical Cancer Research CrossRef